X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Study derives Rogue antibodies linked to COVID-19 clotting

Content Team by Content Team
1st March 2022
in News
Study derives Rogue antibodies linked to COVID-19 clotting

A group of researchers, including those from the National Institutes of Health, discovered “rogue antibodies” that correspond with severe disease and may help explain mechanisms related to significant blood clotting after reviewing blood samples from 244 people admitted for COVID-19. Antiphospholipid antibodies were discovered in the blood, which are more common in people with autoimmune diseases like lupus. A person’s own immune system can, however, help fight off autoantibodies that attack his or her own organs and systems.

The COVID-19 samples had higher levels of the antibody IgG, which collaborates with other immune cells like IgM to react to immunological threats. Higher IgG levels were connected to COVID-19 disease severity, such as those who needed help breathing. The researchers found comparable trends, of a lesser magnitude, in blood samples from 100 individuals hospitalised for sepsis, an inflammatory shock caused by a bacterial or viral infection.

IgG helps the body recognise, respond to, and remember danger by bridging innate and adaptive immunity. These traits normally assist the body in fighting disease and infection. This reaction can become hyperextended or altered, causing disease. The researchers discovered that removing IgG from COVID-19 blood samples reduced molecular signs of “blood vessel stickiness”. The identical IgG antibodies caused an inflammatory reaction in the control samples, which can lead to clotting. Blood clots are a worry that has contributed to the rehospitalisation of COVID-19 patients.

Since every organ has blood vessels, circulating substances that cause healthy blood vessels to stick together during COVID-19 could explain why the virus affects the heart, lungs, and brain. Heart troubles may be common in a post-COVID-19 scenario. Future research could look into the benefits of screening individuals with COVID-19 or other critical illnesses for antiphospholipids as well as other autoantibodies early in the infection process. Acute blood clotting, vascular inflammation, and respiratory failure may be identified. Studies might then analyse the benefits of treating these people to protect blood vessels or regulate the immune system.

Previous Post

Pfizer Joins J&J, Moderna On Price, Tech In Shareholder Vote

Next Post

COPD Teams Up With Ena On Antiviral Nasal Spray For COVID

Related Posts

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Clinical Trials

Cancer Clinical Trials Get A Brand New Platform In Melbourne

3rd November 2022
Next Post
Glenmark and SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets

COPD Teams Up With Ena On Antiviral Nasal Spray For COVID

Latest News

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In